These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 11796397)

  • 1. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bibliographical study of the concurrent existence of anticentromere and antitopoisomerase I antibodies.
    Kikuchi M; Inagaki T
    Clin Rheumatol; 2000; 19(6):435-41. PubMed ID: 11147751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
    Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
    J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
    Falkner D; Wilson J; Medsger TA; Morel PA
    Arthritis Rheum; 1998 Jan; 41(1):74-80. PubMed ID: 9433872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
    Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
    J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
    Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
    Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.
    Bournia VK; Diamanti KD; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Res Ther; 2010; 12(2):R47. PubMed ID: 20302639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis.
    Kuwana M; Inoko H; Kameda H; Nojima T; Sato S; Nakamura K; Ogasawara T; Hirakata M; Ohosone Y; Kaburaki J; Okano Y; Mimori T
    Intern Med; 1999 Apr; 38(4):336-44. PubMed ID: 10361906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitopoisomerase 1 antibodies in systemic sclerosis: how to improve the detection?
    Tamby MC; Bussone G; Mouthon L
    Ann N Y Acad Sci; 2007 Aug; 1109():221-8. PubMed ID: 17785309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
    Weiner ES; Earnshaw WC; Senécal JL; Bordwell B; Johnson P; Rothfield NF
    Arthritis Rheum; 1988 Mar; 31(3):378-85. PubMed ID: 2833902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic SR; Damjanov NS; Vujasinovic Stupar NZ; Baltic S; Babic DD
    Rheumatol Int; 2013 Dec; 33(12):2967-73. PubMed ID: 23934522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
    Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
    Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in systemic sclerosis.
    Vázquez-Abad D; Rothfield NF
    Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
    Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
    Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.